Asp Isotopes Inc
2 nominees · 2 ballot items.
Election of two Class III directors and ratification of EisnerAmper LLP as the independent registered public accounting firm for the 2025 fiscal year.
Follow how the vote landed and what changed on Asp Isotopes Inc’s board — director track records, governance grades, and ongoing monitoring — on the Boardroom Alpha platform.
On the ballot2
- 1
PROPOSAL 1: ELECTION OF CLASS III DIRECTORS
ManagementBoard: FORTwo Class III directors will be elected to serve three-year terms expiring at the 2028 annual meeting; nominees are Sipho N. Maseko and Todd Wider, M.D.
- 2
PROPOSAL 2: RATIFICATION OF APPOINTMENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
ManagementBoard: FORThe audit committee has selected EisnerAmper LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2025; stockholder ratification is requested as a matter of good corporate practice.
Nominees on the ballot2
Top institutional holders10
| # | Owner | % of shares | Shares | Value |
|---|---|---|---|---|
| 1 | Encompass Capital Advisors LLC | 5.5% | 6,912,054 | $31M |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 4.0% | 5,060,464 | $22M |
| 3 | BlackRock, Inc. | 3.5% | 4,406,078 | $19M |
| 4 | Rovida Investment Management Ltd | 3.3% | 4,100,000 | $18M |
| 5 | BlackRock, Inc. | 2.5% | 3,188,516 | $14M |
| 6 | Alyeska Investment Group, L.P. | 2.1% | 2,692,166 | $12M |
| 7 | UBS Group AG | 2.1% | 2,689,045 | $12M |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 2,351,717 | $10M |
| 9 | STATE STREET CORP | 1.8% | 2,322,159 | $10M |
| 10 | EXCHANGE TRADED CONCEPTS, LLC | 1.7% | 2,183,554 | $10M |
Other Basic Materials sector meetings6
Upcoming shareholder meetings at Asp Isotopes Inc’s closest sector peers — compare boards, ballots, and ownership across the cohort.
Frequently asked questions
- When is the Asp Isotopes Inc 2025 annual meeting?
- Asp Isotopes Inc (ASPI) holds its 2025 annual shareholder meeting on Thursday, December 18, 2025.
- What is the record date for the Asp Isotopes Inc 2025 meeting?
- The record date for the Asp Isotopes Inc 2025 meeting is Monday, October 27, 2025. Shareholders of record on or before that date are eligible to vote.
- Who are the director nominees for Asp Isotopes Inc's 2025 meeting?
- The board is presenting 2 director nominees at the Asp Isotopes Inc 2025 meeting, listed with their independence status and background.
- What proposals will shareholders vote on at the Asp Isotopes Inc 2025 meeting?
- Shareholders will vote on 2 proposals at the Asp Isotopes Inc 2025 meeting, each tagged with who proposed it and the board's recommendation.
The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.
This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.
None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.
No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.